Targeted Drug Delivery to ACE2+ Cells Using Engineered Extracellular Vesicles: A Potential Therapeutic Approach for COVID-19

CONCLUSION: These findings indicate promising opportunities for engineered EVs as a novel nanomedicine carrier, offering valuable insights for therapeutic strategies against COVID-19 and other diseases.PMID:38551053 | DOI:10.2174/0113892010282251240324123038

Source: Current Pharmaceutical Biotechnology - March 29, 2024 Category: Biotechnology Authors: Yao Zhang Sheng-Jiao Song Jin He Zhuo-Hua Zhao Ke Zhang Yuan Zhang Xing Li Source Type: research